Keyphrases
Nave
95%
Antipsychotics
95%
First-episode Psychosis
49%
Healthy Controls
49%
Psychosis
46%
Glutamate
45%
Treatment Response
22%
γ-aminobutyric Acid
22%
Dopamine Synthesis
22%
Control Subjects
19%
Caudate
16%
Glutamatergic
14%
Cognitive Function
13%
Patients with Schizophrenia
13%
Dopamine
13%
Motivational Salience
13%
Prediction Model
13%
Positron Emission Tomography
12%
Dopamine Partial Agonist
12%
Schizophrenia
12%
Anterior Cingulate Cortex
12%
Agonism
11%
Early Symptoms
11%
Resting Cerebral Blood Flow
11%
Cerebral Blood Flow
11%
Aminobutyric Acid
11%
Machine Learning
11%
Remission
11%
Symptom Remission
11%
Striatum
11%
Cognitive Level
11%
Glycocalyx Shedding
11%
Response to Treatment
11%
Dorsolateral Prefrontal Cortex (DLPFC)
11%
Clinical Response
11%
Psychotic Symptoms
11%
Dopamine D2 Receptor Agonist
11%
Memory Function
11%
Glycocalyx
11%
Verbal Memory
11%
Illness Onset
11%
Aging Effect
11%
Schizophrenic Patients
11%
Reward Processing
11%
Agonist Treatment
11%
Patient-assessed
11%
Symptom Response
11%
Shedding Patterns
11%
Multimodal Prediction
11%
Dopaminergic Activity
11%
Neuroscience
Antipsychotic
100%
Psychosis
55%
Glutamic Acid
45%
Gamma-Aminobutyric Acid
33%
Positive Syndrome
27%
Dementia Praecox
26%
Thalamus
22%
Anterior Cingulate Cortex
20%
Dorsolateral Prefrontal Cortex
16%
Negative Syndrome
16%
Nucleus Accumbens
14%
Dopamine Agonist
13%
Striatum
12%
Positron Emission Tomography
12%
Fluorine-18
12%
Cognitive Function
12%
Dopaminergic
12%
Aripiprazole
12%
Memory
11%
Decarboxylation
11%
Verbal Memory
11%
Glycocalyx
11%
D2-Receptor Agonists
11%
Dopamine Receptor D2
11%
Neurotransmitter
11%
Dopaminergic Activity
11%
Functional Magnetic Resonance Imaging
7%
DOPA
7%
Nuclear Magnetic Resonance Spectroscopy
6%